OptiBiotix Health (LON:OPTI) Shares Cross Below 50 Day Moving Average – Time to Sell?

Shares of OptiBiotix Health Plc (LON:OPTI) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 5.95 and traded as low as GBX 5.50. OptiBiotix Health shares last traded at GBX 5.50, with a volume of 189 shares changing hands.

OptiBiotix Health Trading Down 2.7%

The firm has a market capitalization of £5.68 million, a price-to-earnings ratio of -1.43 and a beta of 1.82. The company’s 50 day moving average is GBX 5.95 and its 200-day moving average is GBX 5.86.

OptiBiotix Health (LON:OPTI) last announced its quarterly earnings results on Thursday, May 28th. The company reported GBX (3.84) earnings per share for the quarter. The business had revenue of GBX 117 million for the quarter. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.

Insider Activity

In other OptiBiotix Health news, insider David Blain bought 158,965 shares of OptiBiotix Health stock in a transaction dated Thursday, May 28th. The stock was bought at an average cost of GBX 6 per share, for a total transaction of £9,537.90. 26.79% of the stock is currently owned by insiders.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.